vs
阿普塔集团（ATR）与PINTEREST, INC.（PINS）财务数据对比。点击上方公司名可切换其他公司
PINTEREST, INC.的季度营收约是阿普塔集团的1.4倍（$1.3B vs $962.7M），PINTEREST, INC.净利率更高（21.0% vs 7.7%，领先13.3%），PINTEREST, INC.同比增速更快（14.3% vs 13.5%），PINTEREST, INC.自由现金流更多（$380.4M vs $96.9M），过去两年PINTEREST, INC.的营收复合增速更高（33.5% vs 2.6%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
Pinterest是美国社交媒体服务商，主打数字图板形式的信息发布与发现功能，用户可通过图片分享获取食谱、家居、穿搭、创意灵感等多元内容。公司由本·西尔伯曼、保罗·夏拉、埃文·夏普联合创立，总部位于旧金山。
ATR vs PINS — 直观对比
营收规模更大
PINS
是对方的1.4倍
$962.7M
营收增速更快
PINS
高出0.8%
13.5%
净利率更高
PINS
高出13.3%
7.7%
自由现金流更多
PINS
多$283.5M
$96.9M
两年增速更快
PINS
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $1.3B |
| 净利润 | $74.3M | $277.1M |
| 毛利率 | — | 82.8% |
| 营业利润率 | 11.0% | 22.8% |
| 净利率 | 7.7% | 21.0% |
| 营收同比 | 13.5% | 14.3% |
| 净利润同比 | -26.4% | -85.0% |
| 每股收益（稀释后） | $1.13 | $0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRPINS
| Q4 25 | $962.7M | $1.3B | ||
| Q3 25 | $961.1M | $1.0B | ||
| Q2 25 | $966.0M | $998.2M | ||
| Q1 25 | $887.3M | $855.0M | ||
| Q4 24 | $848.1M | $1.2B | ||
| Q3 24 | $909.3M | $898.4M | ||
| Q2 24 | $910.1M | $853.7M | ||
| Q1 24 | $915.4M | $740.0M |
净利润ATRPINS
| Q4 25 | $74.3M | $277.1M | ||
| Q3 25 | $127.9M | $92.1M | ||
| Q2 25 | $111.7M | $38.8M | ||
| Q1 25 | $78.8M | $8.9M | ||
| Q4 24 | $100.9M | $1.8B | ||
| Q3 24 | $100.0M | $30.6M | ||
| Q2 24 | $90.5M | $8.9M | ||
| Q1 24 | $83.1M | $-24.8M |
毛利率ATRPINS
| Q4 25 | — | 82.8% | ||
| Q3 25 | — | 79.8% | ||
| Q2 25 | — | 79.7% | ||
| Q1 25 | — | 76.7% | ||
| Q4 24 | — | 82.9% | ||
| Q3 24 | — | 79.1% | ||
| Q2 24 | — | 78.3% | ||
| Q1 24 | — | 75.5% |
营业利润率ATRPINS
| Q4 25 | 11.0% | 22.8% | ||
| Q3 25 | 14.2% | 5.6% | ||
| Q2 25 | 14.9% | -0.4% | ||
| Q1 25 | 12.8% | -4.1% | ||
| Q4 24 | 14.2% | 22.7% | ||
| Q3 24 | 15.2% | -0.7% | ||
| Q2 24 | 13.8% | -2.5% | ||
| Q1 24 | 12.2% | -7.4% |
净利率ATRPINS
| Q4 25 | 7.7% | 21.0% | ||
| Q3 25 | 13.3% | 8.8% | ||
| Q2 25 | 11.6% | 3.9% | ||
| Q1 25 | 8.9% | 1.0% | ||
| Q4 24 | 11.9% | 160.1% | ||
| Q3 24 | 11.0% | 3.4% | ||
| Q2 24 | 9.9% | 1.0% | ||
| Q1 24 | 9.1% | -3.4% |
每股收益（稀释后）ATRPINS
| Q4 25 | $1.13 | $0.41 | ||
| Q3 25 | $1.92 | $0.13 | ||
| Q2 25 | $1.67 | $0.06 | ||
| Q1 25 | $1.17 | $0.01 | ||
| Q4 24 | $1.48 | $2.66 | ||
| Q3 24 | $1.48 | $0.04 | ||
| Q2 24 | $1.34 | $0.01 | ||
| Q1 24 | $1.23 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $969.3M |
| 总债务越低越好 | $1.1B | — |
| 股东权益账面价值 | $2.7B | $4.7B |
| 总资产 | $5.3B | $5.5B |
| 负债/权益比越低杠杆越低 | 0.43× | — |
8季度趋势，按日历期对齐
现金及短期投资ATRPINS
| Q4 25 | $409.5M | $969.3M | ||
| Q3 25 | $264.8M | $1.1B | ||
| Q2 25 | $169.8M | $1.2B | ||
| Q1 25 | $136.8M | $1.3B | ||
| Q4 24 | $226.2M | $1.1B | ||
| Q3 24 | $327.9M | $1.0B | ||
| Q2 24 | $223.9M | $1.4B | ||
| Q1 24 | $201.1M | $1.6B |
总债务ATRPINS
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — | ||
| Q1 24 | $680.4M | — |
股东权益ATRPINS
| Q4 25 | $2.7B | $4.7B | ||
| Q3 25 | $2.8B | $4.8B | ||
| Q2 25 | $2.7B | $4.8B | ||
| Q1 25 | $2.5B | $4.7B | ||
| Q4 24 | $2.5B | $4.8B | ||
| Q3 24 | $2.5B | $2.9B | ||
| Q2 24 | $2.4B | $3.2B | ||
| Q1 24 | $2.3B | $3.1B |
总资产ATRPINS
| Q4 25 | $5.3B | $5.5B | ||
| Q3 25 | $5.1B | $5.5B | ||
| Q2 25 | $4.9B | $5.4B | ||
| Q1 25 | $4.5B | $5.3B | ||
| Q4 24 | $4.4B | $5.3B | ||
| Q3 24 | $4.6B | $3.5B | ||
| Q2 24 | $4.5B | $3.7B | ||
| Q1 24 | $4.4B | $3.7B |
负债/权益比ATRPINS
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | $391.2M |
| 自由现金流经营现金流 - 资本支出 | $96.9M | $380.4M |
| 自由现金流率自由现金流/营收 | 10.1% | 28.8% |
| 资本支出强度资本支出/营收 | 9.0% | 0.8% |
| 现金转化率经营现金流/净利润 | 2.47× | 1.41× |
| 过去12个月自由现金流最近4个季度 | $299.6M | $1.3B |
8季度趋势，按日历期对齐
经营现金流ATRPINS
| Q4 25 | $183.7M | $391.2M | ||
| Q3 25 | $177.6M | $321.7M | ||
| Q2 25 | $126.0M | $207.7M | ||
| Q1 25 | $82.7M | $363.7M | ||
| Q4 24 | $178.2M | $254.0M | ||
| Q3 24 | $229.3M | $248.0M | ||
| Q2 24 | $143.6M | $106.4M | ||
| Q1 24 | $92.3M | $356.1M |
自由现金流ATRPINS
| Q4 25 | $96.9M | $380.4M | ||
| Q3 25 | $114.3M | $318.4M | ||
| Q2 25 | $62.5M | $196.7M | ||
| Q1 25 | $25.9M | $356.4M | ||
| Q4 24 | $112.2M | $250.2M | ||
| Q3 24 | $162.7M | $244.1M | ||
| Q2 24 | $75.4M | $101.6M | ||
| Q1 24 | $16.7M | $344.0M |
自由现金流率ATRPINS
| Q4 25 | 10.1% | 28.8% | ||
| Q3 25 | 11.9% | 30.3% | ||
| Q2 25 | 6.5% | 19.7% | ||
| Q1 25 | 2.9% | 41.7% | ||
| Q4 24 | 13.2% | 21.7% | ||
| Q3 24 | 17.9% | 27.2% | ||
| Q2 24 | 8.3% | 11.9% | ||
| Q1 24 | 1.8% | 46.5% |
资本支出强度ATRPINS
| Q4 25 | 9.0% | 0.8% | ||
| Q3 25 | 6.6% | 0.3% | ||
| Q2 25 | 6.6% | 1.1% | ||
| Q1 25 | 6.4% | 0.9% | ||
| Q4 24 | 7.8% | 0.3% | ||
| Q3 24 | 7.3% | 0.4% | ||
| Q2 24 | 7.5% | 0.6% | ||
| Q1 24 | 8.3% | 1.6% |
现金转化率ATRPINS
| Q4 25 | 2.47× | 1.41× | ||
| Q3 25 | 1.39× | 3.49× | ||
| Q2 25 | 1.13× | 5.36× | ||
| Q1 25 | 1.05× | 40.77× | ||
| Q4 24 | 1.77× | 0.14× | ||
| Q3 24 | 2.29× | 8.12× | ||
| Q2 24 | 1.59× | 11.98× | ||
| Q1 24 | 1.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
PINS
| United States And Canada | $944.3M | 72% |
| Other | $375.0M | 28% |
